Bone morphogenetic protein can replace autogenous bone

May 23, 2014
Bone morphogenetic protein can replace autogenous bone

(HealthDay)—Bone morphogenetic protein (BMP) is a good alternative to autogenous bone graft in certain cases of lumbar arthrodesis for degenerative disc disease (DDD), according to research published in the May issue of the Journal of Spinal Disorders & Techniques.

Andriy Noshchenko, Ph.D., from the University of Colorado in Aurora, and colleagues conducted a systematic literature review to identify studies comparing the perioperative and long-term postoperative effectiveness of BMP versus iliac crest autologous bone graft (ICBG) for lumbar arthrodesis in adults with DDD.

The researchers identified eight randomized controlled clinical trials (1,138 participants). The BMP and ICBG groups had similar pooled two-year postoperative clinical outcomes. There was increased pain and complications at the donor site (P < 0.01) associated with ICBG. With BMP, the pooled average operative time was 21 minutes less than with ICBG (P < 0.001). In the BMP group, the pooled rate of additional surgical treatment was two times less than in the ICBG groups (P = 0.006). Additionally, at 24-month follow-up, the pooled risk of nonunion was two times less in the BMP versus in the ICBG groups (P = 0.037), although this effect may have been biased.

"BMP, in particular recombinant human BMP-2, is a good alternative to autogenous , especially in cases when harvesting of autologous bone is contraindicated or undesirable, operation time is limited, and there are no contraindications for BMP use," the authors write. "However, the current study did not reveal evidence robust enough to develop strong medical recommendations concerning BMP use for lumbar arthrodesis in ."

Explore further: Spinal fusion material, BMP, increases risk of benign tumors, not cancer

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Spinal fusion material, BMP, increases risk of benign tumors, not cancer

September 6, 2013
Using a certain bone grafting material for spinal fusion, one of the most common procedures for people with painful vertebral deteriorations, does not appear to result in higher rates of cancer, according to researchers at ...

Gene therapy as a new option for bone defects

December 7, 2012
(Medical Xpress)—Gene therapy involving modified stem cells obtained from fatty tissue and bone marrow could represent a new option for the treatment of severe orthopaedic injuries to the extremities. This treatment has ...

Bone growth factor may increase benign tumors but not malignant cancer

September 6, 2013
Patients undergoing spinal fusion surgery with bone morphogenetic protein (BMP) appear to be at increased risk of benign tumors—but not cancers, reports a study in the September issue of Neurosurgery, official journal of ...

Researchers explore function of cancer-causing gene

March 26, 2014
Developmental biologists at the University of Georgia are discovering new roles for a specific gene known as Max's Giant Associated protein, or MGA. A little studied protein, MGA appears to control a number of developmental ...

Arthrodesis ups complications, costs for spondylolisthesis

December 10, 2013
(HealthDay)—For patients with lumbar spondylolisthesis, decompressive laminectomy and spinal arthrodesis is associated with lower reoperation rates, but with higher complication rates and higher overall costs than laminectomy ...

Recommended for you

More surprises about blood development—and a possible lead for making lymphocytes

January 22, 2018
Hematopoietic stem cells (HSCs) have long been regarded as the granddaddy of all blood cells. After we are born, these multipotent cells give rise to all our cell lineages: lymphoid, myeloid and erythroid cells. Hematologists ...

How metal scaffolds enhance the bone healing process

January 22, 2018
A new study shows how mechanically optimized constructs known as titanium-mesh scaffolds can optimize bone regeneration. The induction of bone regeneration is of importance when treating large bone defects. As demonstrated ...

Researchers illustrate how muscle growth inhibitor is activated, could aid in treating ALS

January 19, 2018
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for ...

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.